NClip

Medication Rights at Three Checkpoint Verification

4 min na pagbabasa

Medication Rights at Three Checkpoint Verification

Mahahalagang Punto

  • Ang limang core rights ay right patient, right drug, right route, right time, at right dose.
  • Kabilang sa dagdag na safety rights ang right reason, right documentation, at right response.
  • Kabilang sa expanded pre-administration checks ang right history/assessment, right interaction screening, right education/information, at informed right of refusal handling.
  • Vine-verify ang core rights sa tatlong checkpoint: obtaining, preparing, at bedside administration.
  • Sinusuportahan ng BCMA ang rights verification at maaaring magbigay ng high-risk alerts bago ang administration.
  • Itinuturing ang three-checkpoint verification bilang standard-of-care expectation sa bawat medication administration event.
  • Dapat gumamit ng four-digit military notation sa MAR/eMAR ang right-time verification upang maiwasan ang AM/PM ambiguity.
  • Karaniwang sumusunod ang right-time administration sa facility timing windows (madalas humigit-kumulang +/-30 to 60 minutes ayon sa policy), ngunit ang time-critical medications ay nangangailangan ng mas mahigpit na interval adherence.
  • Dapat kabilang sa pre-injection assessment ang review ng current condition/history, allergy-reaction profile, baseline clinical/lab status (kabilang ang renal/hepatic function kung relevant), at patient medication understanding.

Balangkas ng medication-administration rights kabilang ang right patient, drug, dose, route, time, documentation, at response Illustration reference: OpenStax Pharmacology Ch.2.1.

Kagamitan

  • MAR at active medication order access
  • Patient identifiers (armband at verbal confirmation kung posible)
  • Medication labels at dosage-calculation support
  • BCMA scanner at workstation access

Mga Hakbang ng Procedure

  1. Kumpirmahin ang right patient gamit ang hindi bababa sa dalawang identifiers at huwag kailanman gumamit ng room number bilang identifier.
  2. Ihambing ang MAR/eMAR sa active prescriber order para sa completeness at consistency bago kunin ang medication.
  3. Sa medication retrieval, ihambing ang label sa order para sa right drug, right dose, right route, at right time.
  4. Sa paghahanda, ulitin ang label-order comparison at i-verify ang expiration date at allergy status; kung may allergy conflict, huwag ihanda/ibigay at i-notify ang provider.
  5. Sa bedside, kumpletuhin ang third rights check bago ang administration, kabilang ang route feasibility; kung kailangang baguhin ang route, kumuha muna ng bagong provider order bago ibigay ang medication.
  6. Kumpirmahin ang right time sa pamamagitan ng pag-check ng prescribed frequency at kung kailan naibigay ang huling dose, gamit ang MAR/eMAR four-digit military notation (halimbawa 0700, 1900) sa halip na AM/PM wording.
  7. Ilapat ang facility medication-time policy windows (karaniwang humigit-kumulang 30 to 60 minutes bago/pagkatapos ng scheduled time ayon sa policy) at unahin ang eksaktong interval timing para sa time-critical drugs (halimbawa q8h antibiotics).
  8. Kumpirmahin ang right reason sa pamamagitan ng pag-uugnay ng medication mechanism sa kasalukuyang indication.
  9. Kumpletuhin ang expanded safety checks: i-verify ang relevant history/assessment data (kabilang ang current condition, past medical/medication history, pre-dose vital-sign at lab parameters gaya ng renal/hepatic function kapag clinically relevant, at PRN indication baseline), suriin ang interaction risks (drug-drug, drug-food, drug-condition), suriin ang evidence-based drug reference para sa onset/peak/action at key nursing considerations, magbigay ng medication education (inaasahang therapeutic at adverse effects kasama ang side-effect reporting instructions), at sundin ang informed refusal workflow kapag naaangkop.
  10. Para sa minors o capacity-limited patients, iayon ang medication-information sharing at consent/refusal pathways sa governing law at organizational policy (halimbawa parent/legal guardian notification requirements).
  11. Gamitin ang BCMA scanning ng patient armband at medication label upang palakasin ang rights verification at suriin ang generated alerts (halimbawa allergy flags, pre-dose vital-sign checks, at second-clinician verification prompts).
  12. I-administer lamang ang medication kapag natugunan ang lahat ng rights checks at walang unresolved alert.
  13. Kumpletuhin ang right documentation agad pagkatapos ng administration at i-record ang kinakailangang detalye.
  14. Suriin ang right response sa pamamagitan ng pag-evaluate kung nangyari ang desired effect at i-document ang findings.

Mga Karaniwang Pagkakamali

  • Pag-skip sa isa sa tatlong checkpoints → mas mataas na wrong-patient o wrong-drug risk.
  • Pagpapatuloy kahit may unresolved BCMA o allergy alert → maiiwasang adverse-event risk.
  • Hindi kumpletong right-reason review → naibigay ang medication nang walang malinaw na indication.
  • Pag-skip sa pre-dose hold-parameter review (vitals/labs/PRN baseline) → maiiwasang physiologic deterioration risk.
  • Naantalang documentation at response reassessment → mahinang continuity at missed deterioration.
  • AM/PM versus military-time mismatch habang right-time check → early/late o duplicate-dose risk.
  • Paglalapat ng routine timing windows sa time-critical medications → subtherapeutic levels at maiiwasang treatment failure risk.

Kaugnay

Graph View

Mga Backlink